1st International Meeting on Molecular-Based Treatment of GI-Cancer

The treatment of gastrointestinal cancer (GI-Cancer) is complex and frequently involves different clinical disciplines and multimodal approaches. The relevant endpoints are improved disease free and overall survival as well as low treatment-associated toxicity. However, up to now we are unable to predict treatment response, toxicity and prognosis of individual patients. The application of high-throughput screening tools for genome mutations and transcriptional changes provides novel and critical insights into deregulated pathways in cancer. The translation of this knowledge to the clinic will contribute to the individualization of therapeutic interventions and to improved outcome.

The meeting will gather an outstanding panel of international experts from multiple disciplines to identify approaches to predict and optimize cancer treatment based on the molecular biology of both the tumor and the patient. The meeting will comprehensively cover topics ranging from molecular biology, high-throughput screens, biostatistics, pathology and pathway analysis in GI-Cancer.

We cordially invite you to join us in Göttingen for two interesting late Summer days in the historical Pauliner Church to discuss the realization of molecular medicine for patients with GI-Cancer.

Michael Ghadimi            Heinz Becker
Josef Rüschoff               Thomas Ried